These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7913539)

  • 1. Remoxipride and raclopride differ from metoclopramide by their effects on striatal dopamine release and biosynthesis in rats.
    Guinetdinov RR; Bogdanov MB; Kudrin VS; Rayevsky KS
    Neuropharmacology; 1994 Feb; 33(2):215-9. PubMed ID: 7913539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR; Budygin EA; Kovalev GI; Kudrin VS; Raevskiĭ KS
    Biull Eksp Biol Med; 1992 Jul; 114(7):47-9. PubMed ID: 1358258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of the neurochemical profiles of remoxipride, raclopride and metoclopramide activity].
    Gaĭnetdinov RR; Bogdanov MB; Kudrin VS; Budygin EA; Kovalev GI; Raevskiĭ KS
    Biull Eksp Biol Med; 1992 Jul; 114(8):165-8. PubMed ID: 1467481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
    Magnusson O; Fowler CJ; Mohringe B; Wijkström A; Ogren SO
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):379-84. PubMed ID: 2900472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous monitoring of dopamine, its metabolites and trans-isomer of atypical neuroleptic drug carbidine concentrations in striatal dialysates of conscious rats.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Feb; 20(2):291-305. PubMed ID: 8861194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remoxipride and raclopride differentially alter the activity of incertohypothalamic dopaminergic neurons.
    Eaton MJ; Tian Y; Lookingland KJ; Moore KE
    Neuropharmacology; 1992 Nov; 31(11):1121-6. PubMed ID: 1475021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of remoxipride and aromatic ring metabolites in the rat.
    Ahlenius S; Ericson E; Hillegaart V; Nilsson LB; Salmi P; Wijkström A
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1356-66. PubMed ID: 9400011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
    Hertel P; Nomikos GG; Iurlo M; Svensson TH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):74-86. PubMed ID: 8935802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.
    Johansson C; Jackson DM; Svensson L
    Psychopharmacology (Berl); 1994 Dec; 116(4):437-42. PubMed ID: 7701046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
    Westlind-Danielsson A; Gustafsson K; Andersson I
    Eur J Pharmacol; 1994 Dec; 288(1):89-95. PubMed ID: 7705472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
    Ogren SO; Rosén L; Fuxe K
    Neuroscience; 1994 Jul; 61(2):269-83. PubMed ID: 7969908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O; Mohringe B; Fowler CJ
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
    Guinetdinov RR; Bogdanov MB; Pogorelov VM; Kudrin VS; Rayevsky KS
    Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of remoxipride and raclopride on nigrostriatal and mesolimbic dopaminergic neuronal activity and on the secretion of prolactin and alpha-melanocyte-stimulating hormone.
    Eaton MJ; Tian Y; Lookingland KJ; Moore KE
    Neuropsychopharmacology; 1992 Nov; 7(3):205-11. PubMed ID: 1326981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
    Ericson H; Ross SB
    Eur J Pharmacol; 1992 Jun; 226(2):157-61. PubMed ID: 1353452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats.
    See RE; Chapman MA; Meshul CK
    Synapse; 1992 Oct; 12(2):147-54. PubMed ID: 1362290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of the neurochemical profiles of carbidine stereoisomers].
    Gaĭnetdinov RR; Miroshnichenko II; Kudrin VS; Bogdanov MB; Pogorelov VM; Budygin EA; Kovalev GI; Raevskiĭ KS
    Eksp Klin Farmakol; 1993; 56(1):24-7. PubMed ID: 8100728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.
    Hall H; Sällemark M
    Pharmacol Toxicol; 1987 May; 60(5):359-63. PubMed ID: 2886988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.